Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 360 results:
Συντάκτης Τίτλος Τύπος [ Έτος] Φίλτρα: Συντάκτης is Polyzos, Stergios A [Clear All Filters]
Review: Impact of Helicobacter pylori on Alzheimer's disease: What do we know so far?.
Helicobacter. 23(1),
(2018). Sarcopenic obesity..
Hormones (Athens). 17(3), 321-331.
(2018). Sixty-six years of Metabolism, Clinical and Experimental: The journey of a journal and opportunities and challenges looking ahead..
Metabolism. 78, A4-A9.
(2018). THERAPY OF ENDOCRINE DISEASE: Denosumab vs bisphosphonates for the treatment of postmenopausal osteoporosis..
Eur J Endocrinol. 179(1), R31-R45.
(2018). Thyroid dysfunction and non-alcoholic fatty liver disease..
Minerva Endocrinol. 43(3), 367-376.
(2018). Active Infection Is a Risk Factor for Colorectal Mucosa: Early and Advanced Colonic Neoplasm Sequence..
Gut Liver. 11(5), 733-734.
(2017). Adipose tissue, obesity and non-alcoholic fatty liver disease..
Minerva Endocrinol. 42(2), 92-108.
(2017). Cardio-cerebrovascular disease and Helicobacter pylori-related metabolic syndrome: We consider eradication therapy as a potential cardio-cerebrovascular prevention strategy..
Int J Cardiol. 229, 17-18.
(2017).
(2017). Clinical Features of 24 Patients With Rebound-Associated Vertebral Fractures After Denosumab Discontinuation: Systematic Review and Additional Cases..
J Bone Miner Res. 32(6), 1291-1296.
(2017). Comment on "Effect of biofilm formation by clinical isolates of Helicobacter pylori on the efflux-mediated resistance to commonly used antibiotics"..
World J Gastroenterol. 23(33), 6194-6196.
(2017). Effects of combined low-dose spironolactone plus vitamin E vs vitamin E monotherapy on insulin resistance, non-invasive indices of steatosis and fibrosis, and adipokine levels in non-alcoholic fatty liver disease: a randomized controlled trial..
Diabetes Obes Metab. 19(12), 1805-1809.
(2017). Endocrine and metabolic disorders interplaying with non-alcoholic fatty liver disease..
Minerva Endocrinol. 42(2), 89-91.
(2017). Helicobacter pylori eradication to prevent cardio-cerebrovascular disease: Are current data useful for clinical practice?.
Int J Cardiol. 233, 92.
(2017). Helicobacter pylori on portal hypertension-related hepatic encephalopathy..
Immunopharmacol Immunotoxicol. 39(2), 105-106.
(2017). Helicobacter pylori-related chronic hepatitis C infection and the risk for cardiovascular disease..
Liver Int. 37(7), 1082.
(2017). Helicobacter pylori-related metabolic syndrome as predictor of progression to esophageal carcinoma in a subpopulation-based Barrett's esophagus cohort..
Gastrointest Endosc. 85(2), 462-463.
(2017). Impact of reactive oxygen species generation on Helicobacter pylori-related extragastric diseases: a hypothesis..
Free Radic Res. 51(1), 73-79.
(2017). The intriguing connections of leptin to hyperparathyroidism..
Endocrine. 57(3), 376-387.
(2017). Lipodystrophy: Time for a global registry and randomized clinical trials to assess efficacy, safety and cost-effectiveness of established and novel medications..
Metabolism. 72, A4-A10.
(2017). Low periostin levels in adult patients with Langerhans cell histiocytosis are independently associated with the disease activity..
Metabolism. 71, 198-201.
(2017). Nonalcoholic fatty liver disease: Updates on associations with the metabolic syndrome and lipid profile and effects of treatment with PPAR-γ agonists..
Metabolism. 66, 64-68.
(2017). Novel aspects of defensins' involvement in virus-induced autoimmunity in the central nervous system..
Med Hypotheses. 102, 33-36.
(2017). Obesity and the nervous system: more questions..
Lancet Neurol. 16(10), 772-773.
(2017). Periostin and sclerostin levels in juvenile Paget's disease..
Clin Cases Miner Bone Metab. 14(2), 269-271.
(2017).